Diabetic Foot Ulcer Analysis

Introduction Diabetes mellitus is a global health problem that affects more than 387 million individuals which leads to multiple comorbidities and estimates a loss of $245 billion in medical cost and loss of wage (Tchanque-Fossuo, et al., 2016). One of the most common and serious complication of diabetes mellitus is diabetic foot ulcer. Approximately 15% percent of diabetic patients will develop a foot ulcer in their lifetime and 6-40% of diabetic patients must receive a limb amputation (Kajagar, Godhi, Pandit, & Khatri, 2012). Currently, diabetic foot ulcer accounts for more than 60% percent of non-traumatic lower limb amputation (Tchanque-Fossuo, et al., 2016). Diabetic foot ulcer is very difficult to treat and manage due to impaired wound healing related to the disease process and the increased risk of infection (Tchanque-Fossuo, et al., 2016). These ulcers may also contribute to decreased mobility and a diminished quality of life. With non-healing diabetic foot ulcers becoming more problematic,
This was a level III one-group quasi-experimental design that studied if low-level laser therapy improved the healing of diabetic foot ulcers. The sample used was seven type-II diabetes with grade 2 or 3 foot ulcers. The data collected was measurements of the ulcer surface area, ulcer height, duration, and A1C. The Braden Scale was used to determine the ulcer risk of the participants. The data was collected before the study and after the study concluded along with a six-month follow-up. All wounds were completed recovered after nineteen sessions and was concluded the low-level laser therapy, improved healing of diabetic foot ulcers (Kazemi-Khoo, 2006). The limitation of this experiment disclosed by the researcher was the small sample size and a greater sample would be needed to test